Publication date: Dec 01, 2025
This systematic qualitative review aimed to provide an in-depth understanding of the emotional experiences and coping strategies of home-dwelling older adults, as expressed in their own words, during the quarantine period of the COVID-19 pandemic. Electronic searches were conducted in PsycINFO, CINAHL, Scopus, Web of Science, PubMed, and other related databases. Articles published between January 2020 and December 2021 were identified using predefined keywords. After screening studies based on inclusion and exclusion criteria, relevant data were extracted, and the results were synthesized. The quality of the included studies was assessed using the COREQ checklist. A total of 43 qualitative studies were included in the final review. Based on COREQ evaluation, most studies demonstrated good methodological quality, with a mean score of 25. 81 out of 32 (range: 17-29); no study fully satisfied all COREQ criteria. Thematic synthesis revealed two main categories: (i) Emotional Challenges, which encompassed psychological, physical, technological, and social dimensions; (ii) Coping Strategies, which were classified into cognitive (mindset-based), behavioral (function-based), and technology-assisted strategies. These findings highlight the emotional complexity and adaptability of older adults during isolation. Contrary to initial assumptions of vulnerability, many older adults approached the pandemic with rational understanding and adaptive responses. By drawing on past life experiences, they actively organized coping mechanisms to navigate the crisis. These insights emphasize the need for health policymakers to invest in resilience-building initiatives, such as digital literacy training and community-based emotional and physical support programs. Such strategies can enhance the quality of life for older adults and promote efficient resource utilization within health systems.

Open Access PDF
| Concepts | Keywords |
|---|---|
| Coronavirus | aged |
| Databases | coping strategies |
| December | COVID‐19 pandemic |
| Efficient | emotional resilience |
| Pandemic | isolation |
| older adults | |
| qualitative systematic review |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Coronavirus Disease 2019 |
| disease | MESH | included |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | Severe Acute Respiratory Syndrome |
| disease | MESH | emergency |
| pathway | REACTOME | Reproduction |
| disease | MESH | infections |
| drug | DRUGBANK | Stavudine |
| disease | MESH | death |
| disease | MESH | anxiety |
| pathway | REACTOME | Translation |
| drug | DRUGBANK | Methionine |
| disease | MESH | dis |
| disease | MESH | strains |
| disease | MESH | memory deficits |
| drug | DRUGBANK | Ademetionine |
| drug | DRUGBANK | Aspartame |
| drug | DRUGBANK | Trestolone |
| disease | MESH | sleep disorders |
| disease | MESH | insomnia |
| disease | MESH | bed |
| disease | MESH | chronic diseases |
| disease | MESH | muscle weakness |
| drug | DRUGBANK | Isoxaflutole |
| disease | MESH | arthritis |
| disease | MESH | weight gain |
| drug | DRUGBANK | Cysteamine |
| disease | MESH | fatigue |
| disease | MESH | aids |
| disease | MESH | face |
| disease | MESH | Pneumonia |
| disease | MESH | Metabolic Syndrome |
| disease | MESH | Lam |
| disease | MESH | Aneurysm |
| disease | MESH | Abdominal Aortic Aneurysms |
| drug | DRUGBANK | Vorinostat |
| drug | DRUGBANK | L-Phenylalanine |
| pathway | KEGG | Coronavirus disease |